Clinical Trial

Comparison of Convective Water Vapor Ablation (Convective Water Vapor Energy, WAVE™) With the Rezum™ System Versus Holmium Laser Enucleation of the Prostate (HoLEP) Versus Bipolar Transurethral Resection of the Prostate (TUR-P) in Patients With Benign Prostatic Syndrome (BPS) - A Randomized Study

Study acronym: Vektor
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Benign prostatic enlargement (BPH/BPS) is one of the most common benign diseases in adult men. About 50% of men are affected by the age of 50, and between the ages of 70 and 80 the prevalence rises to 70-80%. There are various surgical procedures available for the treatment of BPH. In this study, we are investigating three surgical procedures which, based on the current data, appear to be relatively equivalent; however, additional data are still needed to substantiate this. The aim of this study is to compare the three surgical methods REZUM vs. HoLEP vs. TUR-P for endoscopic transurethral subvesical de-obstruction with regard to both subjective and objective voiding function, as well as improvements in quality of life and sexual function. The goal of the study is to work out the possible advantages and disadvantages for future patient counseling, thereby defining more precisely the role of these surgical procedures within the armamentarium of urology. This is a single-center, randomized, prospective interventional study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-24.
Trial Details
NCT Number NCT07204002
Lead Sponsor Medical University of Graz
Collaborators: Österreichische Gesellschaft für Urologie
Conditions BPH (Benign Prostatic Hyperplasia), HoLEP, Rezum, TURP(Transurethral Resection of Prostate)
Enrollment 198 participants
Start Date 2025-11-15
Primary Completion 2026-10-15 (estimated)
Study Completion 2030-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-19